LOS ANGELES, CA–(Marketwired – Feb 11, 2014) – Fresh Start Private Management Inc. (OTCQB: CEYY) announces the availability of its revolutionary alcohol treatment program in the Northeast U.S., with the latest opening of a Start Fresh Recovery clinic in Connecticut. The clinic will operate under a distribution arrangement with JPL, LLC. The company previously entered into a definitive agreement just under two months ago, granting JPL the rights to Connecticut. The agreement includes running royalties to Fresh Start Private Management, Inc. for the life of the agreement.
The clinic reports that their doors will open next week, however they are now scheduling appointments for perspective clients by calling 1-855-242-0330 or visiting www.startfreshrecovery.com. They are also beginning an extensive local advertising campaign. The clinic is located at 148 East Ave., Suite 1D Norwalk, CT 06851. Dr. Fallieras, who was recently on the nationally syndicated show, The Doctors, talking extensively about the Start Fresh Program, will serve as the clinic’s medical director.
Kent Emry, CEO of Fresh Start Private, stated, “Norwalk is within the New York City Metropolitan area, and is less than a three hours from Boston, creating an excellent opportunity to help an enormous amount of families. Being in this heavily populated area gives our Start Fresh Program and the company tremendous exposure. We are excited about this important milestone and partnership with JPL. They have moved very quickly in establishing themselves, as this has been the fastest we have seen someone get a clinic up and running.”
About Fresh Start Private (soon to be BioCorRx)
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, visit www.freshstartprivate.com
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
Investor Relations Contact:
Maximum Performance Advisors, Inc.